As schools struggled to stay open during the pandemic, a key question emerged: did the safety measures they put in place actually work? An observational study looking at Georgia elementary schools in late 2020 found that schools requiring masks for teachers and staff saw a 37% lower incidence of COVID-19 compared to schools without such rules. Schools that made ventilation improvements, like bringing in more fresh air or adding filtration, saw a 39% lower incidence. The study involved elementary schools across Georgia during a specific six-week period in November and December of 2020. It's important to understand what this data does and doesn't tell us. This was an observational study, meaning researchers looked at what schools were already doing; they didn't randomly assign schools to different strategies. The results show an association, not proof that these measures caused the lower rates. The study only reports relative percentage changes—like '37% lower'—without providing the actual number of cases, which makes it hard to gauge the real-world impact. The findings are also specific to this time and place, during a surge in Georgia, and may not translate directly to other settings or viral variants.
Did masks and better air help keep Georgia elementary schools safer from COVID-19?
Photo by Navy Medicine / Unsplash
What this means for you:
In Georgia schools, mask rules and better air were linked to fewer COVID-19 cases, but the study has limitations. More on COVID-19
Clozapine Use Linked to Higher SARS-CoV-2 Infection Risk in Severe Mental Disorders Clozapine users faced higher risk of severe COVID-19 in large study
· May 1, 2026
Inactivated SARS-CoV-2 vaccine dosing schedules and antibody responses in adults aged 60 to 80 years Older adults get better protection with the right vaccine booster timing
Frontiers · Apr 30, 2026
Survey finds physicians show stronger intergroup bias than public on vaccines Doctors Show Strong Bias Against Vaccine-Hesitant Patients
medRxiv · Apr 26, 2026
Metformin, fluvoxamine, or ivermectin for non-hospitalized COVID-19 adults in a Phase 3 trial Metformin Cuts Long Covid Risk by 40%
CT.gov · Apr 24, 2026